THE FREQUENCY OF THROMBOTIC COMPLICATIONS AND FEATURES OF GENOTYPES OF POLYMORPHIC MARKERS OF HEMOSTASIS GENES IN CHILDREN WITH NONCOMPACT CARDIOMYOPATHY
Noncompaction cardiomyopathy (NCMP) is characterized by the anomalous myocardium structure and various types of cardiac remodeling, in some cases it is accompanied by thrombotic complications. Preconditions for thrombosis in the disease are unknown, as also there are differences in thrombosis rates between NCMP and other cardiomyopathies, similarly accompanied by the chronic heart failure and analogous remodeling phenotypes. Aim of study is to reveal the difference in the rate of thrombosis in NCMP and dilated cardiomyopathies (DCMP) in children, and to define differences in the frequency of different genotypes of polymorphic markers in an array of hemostasis genes in the two cardiomyopathies. Methods. There was executed a prospective-retrospective cohort study, included patients from the Cardiac Department of the National Scientific and Practical Center of Children's Health from October 2011 to May 2015. The presence of NCMP was established by echocardiography, alleles and genotypes of polymorphic markers of hemostasis and folate cycle genes were determined by polymerase chain reaction in real-time mode. Results. Thrombotic complications in NCMP children were observed more often than in DCMP cases. There were no differences between NCMP and DCMC patients in the frequency of the polymorphic markers c.1691G>A of the F5 gene (p=0.61) , c.20210G>A of the F2 gene (p=1.0) , c.1565T> C of the ITGB3 gene (p=0.32) , 5G(-675)4G of PLANH1 gene (p=0,52) , G(-455)A of FGB gene (p=0.82) , c.677C>T of MTHFR gene (p=0.11). Conclusion Thrombotic complications in NCMP children occur rather more often than in DCMP cases, studied polymorphic markers of the hemostasis and folate cycle genes do not cause this difference, and this requires continuation of the study.
About the authorsBasargina E.N.
Ichida F. Left ventricular noncompaction. Circ. J. 2009; 73 (1): 19-26.
Basargina E.N., Talalaev A.G., Berezneva N.A., Fedorova N.V., Sil’nova I.V. Congenital cardiomyopathy - non-compaction of the myocardium in children. Ros. pediatr. zhurn. 2012; (4): 61-4. (in Russian)
Lilje C., Razek V., Joyce J.J., Rau T., Finckh B.F., Weiss F. et al. Complications of noncompaction of the left ventricular myocardium in a paediatric population: a prospective study. Eur. Heart J. 2006; 27 (15): 1855-60.
Brescia S.T., Rossano J.W., Pignatelli R., Jefferies J.L., Price J.F., Decker J.A. et al. Mortality and sudden death in pediatric left ventricular noncompaction in a tertiary referral center. Circulation. 2013; 127 (22): 2202-8.
Paterick T.E., Umland M.M., Jan M.F., Ammar K.A., Kramer C., Khandheria B.K. et al. Left ventricular noncompaction: a 25-year odyssey. J. Am. Soc. Echocardiogr. 2012; 25 (4): 363-75.
Novo G., Vernuccio F., Fazio G., Grutta G., Lo Voi A., Giambanco S. et al. Left ventricular non compaction: epidemiology, clinical findings, diagnosis and therapy. Minerva Cardioangiol. 2015; 63 (3): 239-51.
Carrilho-Ferreira P., Almeida A.G., Pinto F.J. Non-compaction cardiomyopathy: prevalence, prognosis, pathoetiology, genetics, and risk of cardioembolism. Curr. Heart Fail. Rep. 2014; 11 (4): 393-403.
Umarova M.K., Basargina E.N., Smirnov I.E. Non-compact left ventricular myocardium in children clinical manifestations and prognosis. Ros. pediatr. zhurn. 2016; 19 (3): 174-82. (in Russian)
Cevik C., Shah N., Wilson J.M., Stainback R.F. Multiple left ventricular thrombi in a patient with left ventricular noncompaction. Tex. Heart Inst. J. 2012; 39 (4): 550-3.
Finsterer J. Cardiogenetics, neurogenetics, and pathogenetics of left ventricular hypertrabeculation/noncompaction. Pediatr. Cardiol. 2009; 30 (5): 659-81.
Martín M., Santamarta E., Corros C., Benito E.M., León D., Velasco E. et al. Left ventricle non-compaction cardiomyopathy: different clinical scenarios and magnetic resonance imaging findings. Arch. Cardiol. Mex. 2013; 83 (1): 35-9.
Summers J., Mikolich B. Left ventricular noncompaction: a cardiomyopathy with distinct characteristics and risks. J. Cardiovasc. Nurs. 2014; 29 (6): 535-43.
MacIver D.H. A new understanding and definition of non-compaction cardiomyopathy using analysis of left ventricular wall mechanics and stresses. Int. J. Cardiol. 2014; 174 (3): 819-21.
Chin T.K., Perloff J.K., Williams R.G., Jue K, Mohrmann R. Isolated noncompaction of left ventricular myocardium: a study of eight cases. Circulation. 1990; 82 (5): 507-13.
Jenni R., Oechslin E., Schneider J., Attenhofer Jost C., Kaufmann P.A. Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy. Heart. 2001; 86 (6): 666-71.
Zuccarino F., Vollmer I., Sanchez G., Navallas M., Pugliese F., Gayete A. Left ventricular noncompaction: imaging findings and diagnostic criteria. Am. J. Roentgenol. 2015; 204 (5): 519-30.
Botto L.D., Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am. J. Epidemiol. 2000; 151: 862-77.
Gromyko O.E., Arsen’eva E.N., Nechaeva N.L., Globa O.V., Kuzenkova L.M., Asanov A.Yu. et al. Analysis of polymorphisms of hemostasis and fibrinolysis in children with ischemic stroke. Ros. pediatr. zhurn. 2014; (6): 4-10. (in Russian)
Tavares de Melo M.D., de Araújo Filho J.A., Parga Filho J.R., de Lima C.R., Mady C., Kalil-Filho R. et al. Noncompaction cardiomyopathy: a substrate for a thromboembolic event. BMC Cardiovasc. Disord. 2015; 15: 7. doi: 10.1186/1471-2261-15-7.
Jefferies J.L., Wilkinson J.D., Sleeper L.A., Colan S.D., Lu M., Pahl E. et al. Pediatric cardiomyopathy registry investigators. Cardiomyopathy phenotypes and outcomes for children with left ventricular myocardial noncompaction: Results from the pediatric cardiomyopathy registry. J. Card. Fail. 2015; 21 (11): 877-84.
Umarova M.K., Basargina E.N., Sil’nova I.V. Communication characteristics of non-compact layer of the myocardium with the risk of lethal outcome and development of the thrombotic complications of dilated phenotype non-compaction of the myocardium in children: results from a cohort study. Voprosy sovremennoy pediatrii. 2016; 15 (2): 161-8. (in Russian)
Xing Y., Ichida F., Matsuoka T., Isobe T., Ikemoto Y., Higaki T. et al. Genetic analysis in patients with left ventricular noncompaction and evidence for genetic heterogeneity. Mol. Genet. Metab. 2006; 88 (1): 71-7.
Dong X., Fan P., Tian T., Yang Y., Xiao Y., Yang K. et al. Recent advancements in the molecular genetics of left ventricular noncompaction cardiomyopathy. Clin. Chim. Acta. 2017; 465 (1): 40-4.
Dotsenko O., Kakkar V.V. Antithrombotic therapy in patients with chronic heart failure: rationale, clinical evidence and practical implications. J. Thromb. Haemost. 2007; 5 (2): 224-31.
Fazio G., Corrado G., Zachara E., Rapezzi C., Sulafa A.K., Sutera L. et al. Anticoagulant drugs in noncompaction: a mandatory therapy? J. Cardiovasc. Med. (Hagerstown). 2008; 9 (11): 1095-7.
- Refbacks are not listed
Контент доступен под лицензией Creative Commons Attribution 3.0 License.